Interaction between ketoconazole and domperidone and the risk of QT prolongation - Important safety information

South African Medical Journal

Volumn 96, Issue 7, 2006, Pages 596-

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; AZITHROMYCIN; CLARITHROMYCIN; CYTOCHROME P450 3A4; DOMPERIDONE; ERYTHROMYCIN; KETOCONAZOLE; PYRROLE DERIVATIVE; RITONAVIR; ROXITHROMYCIN;

AREA UNDER THE CURVE; ARTICLE; CANCER PATIENT; DRUG BLOOD LEVEL; DRUG FATALITY; DRUG INFORMATION; DRUG METABOLISM; DRUG SAFETY; HEART VENTRICLE TACHYCARDIA; HUMAN; QT PROLONGATION; RISK ASSESSMENT; SUDDEN DEATH;

ANTIEMETICS; ANTIFUNGAL AGENTS; DOMPERIDONE; DRUG INTERACTIONS; HUMANS; KETOCONAZOLE; LONG QT SYNDROME;

EID: 79651475884     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Drolet B, Rousseau G, Daleau P, Cardinal R, Turgeon J. Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation 2000; 102(16): 1883-1885.
2. Sweetman S, ed. Martindale. The Complete Drug Reference. 34th ed. London: Pharmaceutical Press, 2005: 1263.